DETECTION OF MYCOBACTERIUM TUBERCULOSIS INFECTION BY GENEXPERT AT MILITARY CENTRAL HOSPITAL 108 IN 2023

Thị Hồng Nhung Nguyễn, Tiến Sĩ Bùi, Văn An Nguyễn, Hạ Long Hải Lê

Main Article Content

Abstract

Tuberculosis, caused by Mycobacterium tuberculosis, remains one of the leading causes of mortality from infectious diseases globally. Vietnam ranks among the countries with the highest TB infection rates. Objectives and methods: This cross-sectional study aimed to assess the prevalence of M. tuberculosis infection and rifampicin resistance, and risk factors using the GeneXpert diagnostic system at the 108 Military Central Hospital. Results: Of 875 patients tested, the prevalence of M. tuberculosis infection was 24.8%, with a rifampicin resistance rate of 7.37%. The highest infection rates were observed in men and individuals under 30. Respiratory specimens were more effective for TB detection compared to non-respiratory specimens. Factors such as age, gender, specimen type, and geographic location were not associated significantly with rifampicin-resistance of M. tuberculosis. Conclusion: This study highlights the critical need for stringent management of antibiotic use in TB treatment to curb infection rates and the emergence of drug-resistant strains.

Article Details

References

Bộ Y tế, Báo cáo tổng kết hoạt động chương trình chống lao năm 2023. 2023. p. 1-3.
2. Lê Hoàn và cộng sự, Nhận xét kết quả của xét nghiệm GeneXpert MTB/RIF đờm trong chẩn đoán lao phổi tại Bệnh viện Đại học Y Hà Nội. Tạp chí Nghiên cứu Y học, 2021. 147(11): p. 23-30.
3. Lê Hoàn và cộng sự, Vai trò của xét nghiệm GeneXpert MTB/RIF dịch phế quản trong chẩn đoán lao phổi tại Bệnh viện Đại học Y Hà Nội. Tạp chí Nghiên cứu Y học, 2023. 171(10): p. 299-305.
4. Ardizzoni, E., et al., Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries. PLoS One, 2015. 10(12): p. e0144656.
5. WHO. Global Tuberculosis Report 2017. 2017; Available from: https://www.who.int/publications/ i/item/9789241565516.
6. Diriba, K., E. Awulachew, and G. Churiso, The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia. Infect Drug Resist, 2021. 14: p. 3961-3969.
7. Sunnetcioglu, A., et al., Comparative analysis of pulmonary and extrapulmonary tuberculosis of 411 cases. Ann Clin Microbiol Antimicrob, 2015. 14: p. 34.